Execs On The Move: April 2023
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries. Highlights include the appointment of a new head at the troubled Butterfly Network and Kevin Thornal's jump from Hologic to Nevro, where he is now CEO.
You may also be interested in...
Less than a month after it sold off its reproductive health assets, Invitae has filed for bankruptcy. That will not come as a surprise to anyone following the company.
Freenome, the Roche-backed early cancer detection liquid biopsy developer has raised yet more money, making it one of the best-funded companies in its sub-sector. With trial results due relatively soon, investors are likely hoping this will be the last funding round required before full commercialization.
Osso VR’s platform for the simulation of orthopedic surgical procedures could solve several issues facing the field, according to CEO Justin Barad.